ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 104 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.20 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $417,219 | +172.1% | 139,073 | +239.3% | 0.00% | +200.0% |
| Q2 2023 | $153,310 | -39.4% | 40,992 | -45.8% | 0.00% | -50.0% |
| Q1 2023 | $253,133 | +28.0% | 75,562 | +83.7% | 0.00% | +100.0% |
| Q4 2022 | $197,806 | +4.7% | 41,124 | +54.3% | 0.00% | 0.0% |
| Q2 2022 | $189,000 | -79.0% | 26,656 | -78.6% | 0.00% | -87.5% |
| Q1 2022 | $899,000 | -76.4% | 124,540 | -70.8% | 0.01% | -77.8% |
| Q4 2021 | $3,807,000 | +1254.8% | 425,820 | +5206.2% | 0.04% | +800.0% |
| Q3 2021 | $281,000 | -71.2% | 8,025 | -82.3% | 0.00% | -63.6% |
| Q2 2021 | $976,000 | +222.1% | 45,457 | +827.7% | 0.01% | +175.0% |
| Q1 2021 | $303,000 | – | 4,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |